| 1. |
Abe M, Koga H, Yoshida T, Masuda H, Iwamoto H, Sakata M, Hanada S, Nakamura T, Taniguchi E, Kawaguchi T, Yano H, Torimura T, Ueno T, Sata M. Hepatitis C virus core protein upregulates the expression of vascular endothelial growth factor via the nuclear factor-κB/hypoxia-inducible factor-1α axis under hypoxic conditions. Hepatol Res. 2012 Jan 6. doi: 10.1111/j.1872-034X.2011.00953.x. |
| 2. |
Hino-Arinaga T, Ide T, Kuromatsu R, Miyajima I, Ogata K, Kuwahara R, Hisamochi A, Torimura T, Sata M; Autoimmune Hepatitis Study Group. Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1. J Gastroenterol. 2011 Dec 21. |
| 3. |
Nakamura T, Torimura T, Iwamoto H, Masuda H, Naitou M, Koga H, Abe M, Hashimoto O, Tsutsumi V, Ueno T, Sata M. Prevention of liver fibrosis and liver reconstitution of DMN-treated rat liver by transplanted EPCs. Eur J Clin Invest. 2011 Dec 16. doi: 10.1111/j.1365-2362.2011.02637.x. |
| 4. |
Torimura T, Ueno T, Taniguchi E, Masuda H, Iwamoto H, Nakamura T, Inoue K, Hashimoto O, Abe M, Koga H, Barresi V, Nakashima E, Yano H, Sata M. Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5-fluorocytosine administration suppresses growth of 5-fluorouracil sensitive liver cancer in mice. Cancer Sci. 2011 Dec 8. doi: 10.1111/j.1349-7006.2011.02182.x. |
| 5. |
Sumie S, Kawaguchi T, Kuromatsu R, Takata A, Nakano M, Satani M, Yamada S, Niizeki T, Torimura T, Sata M. Total and high molecular weight adiponectin and hepatocellular carcinoma with HCV infection. PLoS One. 2011;6(11):e26840. |
| 6. |
Koga H, Selvendiran K, Sivakumar R, Yoshida T, Torimura T, Ueno T, Sata M. PPARγ potentiates anticancer effects of gemcitabine on human pancreatic cancer cells. Int J Oncol. 2011 Oct 20. doi: 10.3892/ijo.2011.1237. |
| 7. |
Nakamura T, Tsutsumi V, Torimura T, Naitou M, Iwamoto H, Masuda H, Hashimoto O, Koga H, Abe M, Ii M, Kawamoto A, Asahara T, Ueno T, Sata M. Human peripheral blood CD34-positive cells enhance therapeutic regeneration of chronically injured liver in nude rats. J Cell Physiol. 2011 Jun 15. doi: 10.1002/jcp.22873. |
| 8. |
Kawaguchi T, Kaji R, Horiuchi H, Shirono T, Ishida Y, Okabe Y, Itou M, Mitsuyama K, Akiba J, Nakashima O, Yano H, Kage M, Harada M, Sakisaka S, Sata M. Development of intrahepatic cholangiocarcinoma after a 14-year follow-up of a patient with primary sclerosing cholangitis and ulcerative colitis．Hepatol Res. 2011 41: 1253-59. |
| 9. |
Sakata M, Kawaguchi T, Taniguchi E, Abe M, Koga H, Sata M. Quick and simple method for increasing the reduced albumin fraction in human serum albumin preparations by using stronger neo-minophagen C．Hepatol Res. 2011 41: 1120-25. |
| 10. |
Eslam M, Kawaguchi T, Del Campo JA, Sata M, Abo-Elneen Khattab M, Romero-Gomez M. Use of HOMA-IR in hepatitis C．J Viral Hepat. 2011 18: 675-84. |
| 11. |
Itou M, Kawaguchi T, Taniguchi E, Oriishi T, Suetsugu T, Hano R, Yoshihara M, Takishita M, Eguchi M, Ogiwara Y, Otsuyama J, Mutou M, Ibi R, Akiyama R, Ono M, Otsuka M, Nagamatsu A, Tanaka S, Miyakoda K, Emori K, Morita Y, Kumamoto M, Tsuruta O, Sata M. Supplementation before endoscopic therapy for esophageal varices reduces mental stress in patients with liver cirrhosis. Hepato-Gastroenterology. 2011 58: 814-18. |
| 12. |
Eslam M, Aparcero R, Kawaguchi T, Del Campo JA, Sata M, Khattab MA, Romero-Gomez M．Meta-analysis: insulin resistance and sustained virological response in hepatitis C. Aliment pharmacol Ther. 2011 34: 297-305. |
| 13. |
Kawaguchi T, Taniguchi E, Itou M, Sakata M, Sumie S, Sata M. Insulin resistance and chronic liver disease. World J Hepatol. 2011 3: 99-107. |
| 14. |
Kawaguchi T, Shiba N, Maeda T, Matsugaki T, Takano Y, Itou M, Sakata M, Taniguchi E, Nagata K, Sata M. Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD: a pilot study. J Gastroenterol. 2011 46: 746-57. |
| 15. |
Kawaguchi T, Shiba N, Takano Y, Maeda T, Sata M. Hybrid training of voluntary and electrical muscle contractions decreased fasting blood glucose and serum interleukin-6 levels in elderly people: a pilot study. Appl Physiol Nutr Metab. 2011 36: 276-83. |
| 16. |
Kawaguchi T, Kakuma T, Yatsuhashi H, Watanabe H, Saitsu H, Nakao K, Taketomi A, Ohta S, Tabaru A, Takenaka K, Mizuta T, Nagata K, Komorizono Y, Fukuizumi K, Seike M, Matsumoto S, Maeshiro T, Tsubouchi H, Muro T, Inoue O, Akahoshi M, Sata M. Data mining reveals complex interactions of risk factors and clinical feature profiling associated with the staging of non-hepatitis B virus/non-hepatitis C virus-related hepatocellular carcinoma. Hepatol Res. 2011 41: 564-71. |
| 17. |
Tonan T, Fujimoto K, Qayyum, A, Azuma S, Ishibashi M, Ueno T, Ono N, Akiyoshi J, Matsushita S, Hayabuchi N, Kawaguchi T, Sata M. Correlation of Kupffer cell function and hepatocyte function in chronic viral hepatitis evaluated with superparamagnetic iron oxide-enhanced magnetic resonance imaging and scintigraphy using technetium-99m-labelled galactosyl human serum albumin. Exp Ther Med. 2011 2: 607-13. |
| 18. |
Kawaguchi T, Itou M, Taniguchi E, Sakata M, Abe M, Koga H, Oriishi T, Imamura Y, Kato T, Yamada K, Sata M. Serum level of free fatty acids is associated with nocturnal hypoglycemia in cirrhotic patients with HCV infection: a pilot study. Hepato-Gastroenterology. 2011 58: 103-08. |
| 19. |
Yanagimoto C, Harada M, Kumemura H, Abe M, Koga H, Sakata M, Kawaguchi T, Terada K, Hanada S, Taniguchi E, Ninomiya H, Ueno T, Sugiyama T, Sata M. Copper incorporation into ceruloplasmin is regulated by Niemann-Pick C1 protein. Hepatol Res. 2011 41: 484-91. |
| 20. |
Tsedensodnom O, Koga H, Rosenberg SA, Nambotin SB, Carroll JJ, Wands JR, Kim M. Identification of T-cell factor-4 isoforms that contribute to the malignant phenotype of hepatocellular carcinoma cells. Exp Cell Res. 2011 317: 920-31. |
| 21. |
Fujimoto K, Tonan T, Azuma S, Kage M, Nakashima O, Johkoh T, Hayabuchi N, Okuda K, Kawaguchi T, Sata M, Qayyum A. Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade． Radiology. 2011 258: 739-48. |
| 22. |
Fujimoto K, Kawaguchi T, Nakashima O, Ono J, Ohta S, Kawaguchi A, Tonan T, Ohshima K, Yano H, Hayabuchi N, Izuhara K, Sata M. Periostin, a matrix protein, has potential as a novel serodiagnostic marker for cholangiocarcinoma. Oncol Rep. 2011 25(5): 1211-16. |
| 23. |
Iwamoto H, Torimura T, Nakamura T, Hashimoto O, Inoue K, Kurogi J, Niizeki T, Kuwahara R, Abe M, Koga H, Yano H, Kerbel RS, Ueno T, Sata M. Metronomic S-1 chemotherapy and vandetanib: an efficacious and non-toxic treatment for hepatocellular carcinoma. Neoplasia. 2011 13: 187-97. |
| 24. |
Taniguchi E, Kawaguchi T, Itou M, Oriishi T, Ibi R, Torii M, Yoshida K, Adachi Y, Otsuka M, Uchida Y, Tanaka S, Takakura M, Sata M. Subjective global assessment is not sufficient to screen patients with defective hepatic metabolism. Nutrition. 2011 27: 282-86. |
| 25. |
Yoshida K, Noguchi M, Mine T, Komatsu N, Yutani S, Ueno T, Yanagimoto H, Kawano K, Itoh K, Yamada A. Characteristics of severe adverse events after peptide vaccination for advanced cancer patients: Analysis of 500 cases. Oncol Rep. 2011 25: 57-62. |
| 26. |
Yamaguchi R, Tanaka M, Yokoyama T, Nonaka Y, Mizushima Y, Kawahara A, et al. Cytological features of myxomatous fibroadenoma of the breast. Diagn Cytopathol. 2011. |
| 27. |
Yamaguchi R, Tanaka M, Mizushima Y, Hirai Y, Yamaguchi M, Kaneko Y, Terasaki H , Yokoyama T, Nonaka Y, Yano H. Myxomatous fibroadenoma of the breast: correlation with clinicopathologic and radiologic features. Human pathology. 2011 42(3):419-23. |
| 28. |
Taira T, Kawahara A, Yamaguchi T, Abe H, Ishida Y, Okabe Y, et al. Morphometric image analysis of pancreatic disease by ThinPrep liquid-based cytology. Diagn Cytopathol. 2011. |
| 29. |
Naito Y, Okabe Y, Nagayama M, Nishinakagawa T, Taira T, Kawahara A, Hattori S, Machida K, Ishida Y, Kaji R, Mikagi K, Kinoshita H, Yasumoto M, Akiba J, Kage M, Nakashima M, Ohshima K, Yano H. Accuracy of differential diagnosis for pancreatic cancer is improved in the combination of RCAS1 and CEA measurements and cytology in pancreatic juice. Med Mol Morphol. 2011 44(2):86-92. |
| 30. |
Iizuka N, Oka M, Sakaida I, Moribe T, Miura T, Kimura N, Tamatsukuri S, Ishitsuka H, Uchida K, Terai S, Yamashita S, Okita K, Sakata K, Karino Y, Toyota J, Ando E, Ide T, Sata M, Tsunedomi R, Tsutsui M, Iida M, Tokuhisa Y, Sakamoto K, Tamesa T, Fujita Y, Hamamoto Y．Efficient detection of hepatocellular carcinoma by a hybrid blood test of epigenetic and classical protein markers. Clin Chim Acta. 2011 412: 152-58. |
| 31. |
Akiba J, Harada H, Kawahara A, Arakawa F, Mihashi H, Mihashi R, Ohshima K, Yano H. Histiocytic sarcoma of the parotid gland region. Pathol Int. 2011 61: 373-76. |
| 32. |
Nomura Y, Naito Y, Eriguchi N, Kume T, Itai N, Sonoda H, Hayashida S, Naito S , Naito H, Yasumoto M, Akiba J, Kinoshita H, Yano H, Kage M. A case of IgG4-related sclerosing mesenteritis. Pathol Res Pract. 2011 207: 518-21. |
| 33. |
Akiba J, Murakami Y, Nada M, Watari K, Ogasawara S, Yoshida T, Kawahara A, Sanada S, Yasumoto M, Yamaguchi R, Kage M, Kuwano M, Ono M, Yano H. N-myc downstream regulated gene 1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase. Cancer Letters. 2011 310: 25-34. |
| 34. |
Yamaguchi R, Tanaka M, Yokoyama T, Nonaka H, Kojima K, Terasaki H, et al. Clinicocytopathology of breast cancers with a ring-like appearance on ultrasonography and/or magnetic resonance imaging. Pathol Int. 2010 60(1):22-6. |
| 35. |
Yamaguchi R, Tanaka M, Mizushima Y, Hirai Y, Yamaguchi M, Kaneko Y, et al. Myxomatous fibroadenoma of the breast: correlation with clinicopathologic and radiologic features. Hum Pathol. 2010. |
| 36. |
Yamaguchi R, Tanaka M, Kondo K, Yokoyama T, Kaneko Y, Yamaguchi M, et al. Characteristic morphology of invasive micropapillary carcinoma of the breast: an immunohistochemical analysis. Jpn J Clin Oncol. 2010 40(8):781-7. |
| 37. |
Ogasawara S, Komuta M, Nakashima O, Akiba J, Tsuneoka M, Yano H. Accelerated expression of a Myc target gene Mina53 in aggressive hepatocellular carcinoma. Hepatol Res. 2010 40:330-6. |
| 38. |
Nakanuma Y, Zen Y, Harada K, Sasaki M, Nonomura A, Uehara T, et al. Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement. Pathol Int. 2010 60(3):167-74. |
| 39. |
Iwata Y, Okamoto M, Hoshino T, Kitasato Y, Sakazaki Y, Tajiri M, et al. Elevated levels of thioredoxin 1 in the lungs and sera of idiopathic pulmonary fibrosis, non-specific interstitial pneumonia and cryptogenic organizing pneumonia. Intern Med. 2010 49(22):2393-400. |
| 40. |
Futami K, Ogasawara S, Goto H, Yano H, Furuichi Y. RecQL1 DNA repair helicase: A potential tumor marker and therapeutic target against hepatocellular carcinoma. Int J Mol Med. 2010 25(4):537-45. |
| 41. |
Fujimoto M, Nakashima O, Komuta M, Miyaaki T, Kojiro M, Yano H. Clinicopathological study of hepatocellular carcinoma with peliotic change. Oncology Letters 2010 1(1): 17-21. |
| 42. |
Nagaoka S, Yoshida T, Akiyoshi J, Akiba J, Hisamoto T, Yoshida Y, Abe M, Koga H, Toirimura T, Ueno T, Sata M．The ratio of serum placenta growth factor to soluble vascular endothelial growth factor receptor-1 predicts the prognosis of hepatocellular carcinoma．Oncol Rep. 2010 23: 1647-54. |
| 43. |
Nagamatsu H, Hiraki M, Mizukami N, Yoshida H, Iwamoto H, Sumie S, Torimura T, Sata M．Intra-arterial therapy with cisplatin suspension in lipiodol and 5-fluorouracil for hepatocellular carcinoma with portal vein tumour thrombosis．Aliment Pharmacol Ther. 2010 32: 543-50. |
| 44. |
Fukushima N, Kuroamtsu R, Akiba J, Ando E, Takata A, Sumie S, Nakano M, Nakamura T, Kawahara A, Torimura T, Nakashima O, Okuda K, Yano H, Kage M, Kojiro M, Sata M．Characteristic expression pattern of oxidative stress in livers with cryptogenic hepatocellular carcinoma. Expression and Therapeutic Medicine. 2010 1: 809-16. |
| 45. |
Sakata M, Kawaguchi T, Taniguchi E, Nakayama A, Ishizaki S, Sonaka I, Maganuma M, Nakamura T, Itou M, Oriishi T, Abe M, Yanagimoto C, Koga H, Harada M, Sakamoto T, Oda, S, Sata M．Redox state of albumin is not associated with colloid osmotic pressure．Mol Med Rep. 2010 3: 685-87. |
| 46. |
Sakata M, Kawaguchi T, Taniguchi E, Nakayama A, Ishizaki S, Sonaka I, Nakamura T, Itou M, Oriishi T, Abe M, Yanagimoto C, Koga H, Sata M．Oxidized albumin is associated with water retention and severity of disease in patients with chronic liver diseases．e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism. 2010 5: e247-e292. |
| 47. |
Nakano M, Ando E, Kuromatsu R, Torimura T, Sumie S, Takata A, Fukushima N, Kurogi J, Niizeki T, Iwamoto H, Tanaka M, Sata M．Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan．Hepatol Res. 2010 40: 989-96. |
| 48. |
Toyama T, Lee HC, Koga H, Wands JR, Kim M．Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migration．Mol Cancer Res. 2010 8: 254-65. |
| 49. |
Kaneko S, Sata M, Ide T, Yamashita T, Hige S, Tomita E, Mochida S, Yamashita Y, Inui Y, Kim SR, Komada N, Mikami T, Satoh S, Morita S, Takaguchi K, Hirashima N, Nishio Y, Watanabe D, Kioka K, Fujiwara K．Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C．Hepatol Res. 2010 40: 1072-81. |
| 50. |
Ide T, Sata M, Chayama K, Shindo M, Toyota J, Mochida S, Tomita E, Kumada H, Yamada G, Yatsuhashi H, Hayashi N, Ishikawa H, Seriu T, Omata M．Evaluation of long-term entecavir treatment in stable chronic hepatitis B patients switched from lamivudine therapy．Hepatol Int. 2010 4: 594-600. |
| 51. |
Fukushima N, Kuromatsu R, Arinaga-Hino T, Ando E, Takata A, Sumie S, Nakano M, Kawaguchi T, Ide T, Torimura T, Sata M．Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C．Hepatol Res. 2010 40: 911-22. |
| 52. |
Takata A, Kuromatsu R, Ando E, Iwamoto H, Fukushima N, Sumie S, Torimura T, Sata M．HCC develops even in the early stage of chronic liver disease in elderly patients with HCV infection．Int J Mol Med. 2010 26: 249-56. |
| 53. |
Arii S, Sata M, Sakamoto M, Shimada M, Kumada T, Shiina S, Yamashita T, Kokudo N, Tanaka M, Takayama T, Kudo M．Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009)．Hepatol Res. 2010 40: 667-85. |
| 54. |
Ide T, Sata M, Sakisaka S, Nakamuta M, Fujiyama S, Mizuta T, Tahara K, Fujisaki K, Komorizono Y, Watanabe H, Morita Y, Tsubouchi H．Peginterferon-alpha-2b plus ribavirin therapy in patients with chronic hepatitis C as assessed by a multi-institutional questionnaire in Japan．Hepatol Res. 2010 40: 557-65. |
| 55. |
Nakamura A, Ueno T, Yagi Y, Okuda K, Ogata T, Nakamura T, Torimura T, Iwamoto H, Sivakuma R, Sata M, Tsutsumi V, Yasuda K, Tomiyasu Y, Obayashi K, Tashiro K, Kuhara S．Human primary cultured hepatic stellate cells can be cryopreserved．Med Mol Morphol. 2010 43: 107-15. |
| 56. |
Kawaguchi T, Taniguchi E, Morita Y, Shirachi M, Tateishi I, Nagata E, Sata M．Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection．Liver Int. 2010 30: 479-86. |
| 57. |
Yamasaki H, Mitsuyama K, Masuda J, Tomiyasu N, Takedatsu H, Akashi H, Matsumoto S, Takedatsu H, Kuwaki K, Tsuruta O, Sata M．Mechanisms underlying the effects of leukocyte apheresis with a fiber filter in a rat model of dextran sulfate sodium-induced colitis．Dig Dis Sci. 2010 55: 596-606. |
| 58. |
Kawaguchi T, Yamagishi S, Itou M, Okuda K, Sumie S, Kuromatsu R, Sakata M, Abe M, Taniguchi E, Koga H, Harada M, Ueno T, Sata M．Pigment epithelium-derived factor inhibits lysosomal degradation of Bcl-xL and apoptosis in HepG2 cells．Am J Pathol. 2010 176: 168-76. |
| 59. |
Matsumoto S, Hara T, Mitsuyama K, Yamamoto M, Tsuruta O, Sata M, Scheller J, Rose-John S, Kado S, Takada T. Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model．J Immunol. 2010 184: 1543-51. |
| 60. |
Yamaguchi R, Tanaka M, Yamaguchi M, Fukushima T, Kaneko Y, Otsuka H, Isobe S, Terasaki H, Nakashima O, Kage M, Yano H．Pleomorphic carcinoma of the breast in a 17-year-old woman. Med Mol Morphol. 2010 43: 43-7. |
| 61. |
Nakanuma Y, Zen Y, Harada K, Sasaki M, Nonomura A, Uehara T, Sano K, Kondo F, Fukusato T, Tsuneyama K, Ito M, Wakasa K, Nomoto M, Minato H, Haga H, Kage M, Yano H, Haratake J, Aishima S, Masuda T, Aoyama H, Miyakawa-Hayashino A, Matsumoto T, Sanefuji H, Ojima H, Chen T-C, Yu E, Kim J-H, Park Y N, Tsui W．Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement．Pathol Int. 2010 60: 167-74. |
| 62. |
Futami K, Ogasawara S, Goto H, Yano H, Furuichi Y．RecQL1DNA repair helicase : A potential tumor marker and therapeutic target against hepatocellular carcinoma．Int J Mol Med. 2010 25: 537-45. |
| 63. |
Akiba J, Nakane T, Arakawa F, Ohshima K, Yano H．Collision of EBV-associated gastric carcinoma and primary gastric extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the remnant stomach．Pathol Int. 2010 60 : 102-06. |
| 64. |
Yamaguchi R, Tanaka M, Yokoyama T, Nonaka H, Kojima K, Terasaki H, Yamaguchi M, Fukunaga M, Toh U, Nakashima O, Kage M, Yano H．Clinicocytopathology of breast cancers with a ring - like appearance on ultrasonography and/or magnetic resonance imaging．Pathol Int. 2010 60: 22-6. |
| 65. |
Fujimoto M, Nakashima O, Komuta M, Miyaaki T, Kojiro M, Yano H．Clinicopathological study of hepatocellular carcinoma with peliotic change．Oncology Letters. 2010 1: 17-21. |
| 66. |
Karino Y, Toyota J, Kumada H, Katano Y, Izumi N, Kobashi H, Sata M, Moriyama M, Imazeki F, Kage M, Ishikawa H, Masaki N, Seriu T, Omata M．Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B．Hepatol Int. 2010 4: 414-22. |
| 67. |
Kawaguchi T, Taniguchi E, Morita Y, Shirachi M, Tateishi I, Nagata E, Sata M．Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection．Liver Int. 2010 30: 479-86. |
| 68. |
Nagao Y, Matsuoka H, Kawaguchi T, Sata M． Aminofeel improves the sensitivity to taste in patients with HCV-infected liver disease．Med Sci Monit. 2010 16: PI7-PI12. |
| 69. |
Kanauchi O, Mitsuyama K, Komiyama Y, Yagi M, Akira A, Sata M．Preventive effects of enzyme-treated rice fiber in a restraint stress-induced irritable bowel syndrome model．Int J Mol Med. 2010 25: 547-55. |
| 70. |
Yamasaki H, Mitsuyama K, Masuda J, Tomiyasu N, Takedatsu H, Akashi H, Matsumoto S, Takedatsu H, Kuwaki K, Tsuruta O, Sata M．Mechanisms underlying the effects of leukocyte apheresis with a fiber filter in a rat model of dextran sulfate sodium-induced colitis． Dig Dis Sci. 2010 55: 596-606. |
| 71. |
Kaji R, Okabe Y, Ishida Y, Takedatsu H, Kawahara A, Aino H, Morimitsu Y, Maekawa R, Toyonaga A, Tsuruta O, Sata M．Autoimmune pancreatitis presenting with IgG4-positive multiple gastric polyps． Gastrointest Endosc. 2010 71: 420-22. |
| 72. |
Maruyama Y, Horiuchi H, Okabe Y, Kawahara R, Uchida S, Sakai T, Hisaka T, Ishikawa H, Mikagi K, Yoshitomi M, Kawashima Y, Fujishita M, Akasu G, Katsumoto M, Eto D, Ureshino M, Goto Y, Ureshino H, Kinoshita H．Perioperative challenges associated with a pancreaticoduodenectomy and distal pancreatectomy for pancreatic cancer in patients with situs inversus totalis: report of two cases． Surg Today. 2010 40: 79-82. |
| 73. |
Kawaguchi T, Yamagishi S, Itou M, Okuda K, Sumie S, Kuromatsu R, Sakata M, Abe M, Taniguchi E, Koga H, Harada M, Ueno T, Sata M．Pigment epithelium-derived factor inhibits lysosomal degradation of Bcl-xL and apoptosis in HepG2 cells．Am J Pathol. 2010 176: 168-76. |
| 74. |
Tamiya Y, Nakahara K, Kominato K, Serikawa O, Watanabe Y, Tateishi H, Takedatsu H, Toyonaga A, Sata M．Pneumomediastinum is a frequent but minor complication during esophageal endoscopic submucosal dissection．Endoscopy. 2010 42: 8-14. |
| 75. |
Matsumoto S, Hara T, Mitsuyama K, Yamamoto M, Tsuruta O, Sata M, Scheller J, Rose-John S, Kado S, Takada T．Essential Roles of IL-6 Trans-Signaling in Colonic Epithelial Cells, Induced by the IL-6/Soluble-IL-6 Receptor Derived from Lamina Propria Macrophages, on the Development of Colitis-Associated Premalignant Cancer in a Murine Model．J Immunol. 2010 184: 1543-51. |
| 76. |
Yamaguchi R, Futamata Y, Yoshimura F, Murakami N, Koufuji K, Kutami R, Kojima K, Ohki S, Kurata S, Ishibashi M, Yano H．Mastopathic - type fibroadenoma and ductal adenoma of the breast with false- positive fluorodeoxyglucose positron emission tomography．Jpn J Radiol. 2009 27: 280-84. |
| 77. |
Koga T, Taguchi J, Suzuki M, Higa Y, Kamimura T, Nishimura M, Arakawa M．Cat scratch disease presenting with a retroperitoneal abscess in a patient without animal contacts． J Infect Chemother. 2009 15: 414-16. |
| 78. |
Omary MB, Ku NO, Strnad P, Hanada S．Toward unraveling the complexity of simple epithelial keratins in human disease．J Clin Invest. 2009 119: 1794-1805. |
| 79. |
Morimoto J, Hasegawa Y, Fukushima H, Uesugi N, Hisano S, Saito T, Kaneoka H．Membranoproliferative glomerulonephritis-like glomerular disease and concurrent tubulointerstitial nephritis complicating IgG4-related autoimmune pancreatitis．Intern Med. 2009 48: 157-62. |
| 80. |
Kawaguchi T, Kurumatsu R, Ide T, Taniguchi E, Itou M, Sakata M, Abe M, Sumie S, Sata M．Thrombocytopenia, an important interfering factor of antiviral therapy and hepatocellular carcinoma treatment for chronic liver diseases．Kurume Med J. 2009 56: 9-15. |
| 81. |
Nishihira J, Mitsuyama K．Overview of the role of macrophage migration inhibitory factor (MIF) in inflammatory bowel disease．Curr Pharm Des. 2009 15: 2104-09. |
| 82. |
Niu Y, Komatsu N, Komohara Y, Matsueda S, Yutani S, Ishihara Y, Itou M, Yamada A, Itoh K, Shichijo S．A peptide derived from hepatitis C virus (HCV) core protein inducing cellular responses in patients with HCV with various HLA class IA alleles．J Med Virol. 2009 81: 1232-40. |
| 83. |
Itou M, Mitsuyama K, Kawaguchi T, Okabe Y, Suga H, Masuda J, Yamasaki H, Kuwaki K, Taniguchi E, Harada M, Tsuruta O, Sata M．Leukocytapheresis therapy improved cholestasis in patient with primary sclerosing cholangitis with ulcerative colitis．Case Rep Gastroenterol. 2009 3: 77-83. |
| 84. |
Naito Y, Kinoshita H, Okabe Y, Arikawa S, Higaki K, Morimitsu Y, Yamasaki F, Suda K, Yasumoto M, Kusano H, Nakashima O, Yano H．Pathomorphologic study of undifferentiated carcinoma in seven cases: relationship between tumor and pancreatic duct epithelium. J Hepatobiliary Pancreat Surg. 2009 16: 478-84. |
| 85. |
Matsumoto S, Hara T, Nagaoka M, Mike A, Mitsuyama K, Sako T, Yamamoto M, Kado S, Takada T．A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer. Immunology. 2009 128: e170-e180. |
| 86. |
Hotta K, Nakamura M, Nakamura T, Matsuo T, Nakata Y, Kamohara S, Miyatake N, Kotani K, Komatsu R, Itoh N, Mineo I, Wada J, Masuzaki H, Yoneda M, Nakajima A, Funahashi T, Miyazaki S, Tokunaga K, Kawamoto M, Ueno T, Hamaguchi K, Tanaka K, Yamada K, Hanafusa T, Oikawa S, Yoshimatsu H, Nakao K, Sakata T, Matsuzawa Y, Kamatani N, Nakamura Y．Association between obesity and polymorphisms in SEC16B, TMEM18, GNPDA2, BDNF, FAIM2 and MC4R in a Japanese population. J Hum Genet. 2009 54: 727-31. |
| 87. |
Nagao Y, Michio S．High incidence of multiple primary carcinomas in HCV-infected patients with oral squamous cell carcinoma. Med Sci Monit. 2009 15(9): 453-9. |
| 88. |
Shindo M, Chayama K, Mochida S, Toyota J, Tomita E, Kumada H, Yokosuka O, Sata M, Hayashi N, Suzuki K, Okanoue T, Tsubouchi H, Ishikawa H, Seriu T, Omata M．Antiviral activity, dose-response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial. Hepatol Int. 2009 3: 445-52. |
| 89. |
Naito Y, Okabe Y, Morimitsu Y, Taira T, Kawahara A, Yano H, Kage M．A case of invasive carcinoma derived from intraductal papillary-mucinous carcinoma of the pancreas producing a signet ring-type appearance on pancreatic duct brushing cytology. Cytopathology. 2009 20: 406-08. |
| 90. |
Itou M, Kawaguchi T, Taniguchi E, Shiraichi A, Ibi R, Mutou M, Okada T, Uchida Y, Otuska M, Oriishi T, Tanaka S, Takakura M, Mitsuyama M, Tsuruta O, Sata M．Heating impreves poor compliance with branched chain amino acid-rich supplementation in patients with liver cirrhosis: A before-after pilot study. Mol Med Report. 2009 2: 983-7. |
| 91. |
Itou M, Kawaguchi T, Taniguchi E, Oku Y, Fukushima N, Ando E, Oriishi T, Uchida Y, Otuska M, Tanaka S, Iwasaki S, Torii M, Yoshida K, Adachi Y, Suga M, Yoshiyama M, Ibi R, Akiyama Y, Takakura M, Mitsuyama K, Tsuruta O, Sata M．Branched-chain amino acid supplements reduced ascites and increased the quality of life in a patient with liver cirrhosis: A case report. Mol Med Report. 2009 2: 977-81. |
| 92. |
Iwasaki Y, Shiratori Y, Hige S, Nishiguchi S, Takagi H, Onji M, Yoshida H, Izumi N, Kohgo Y, Yamamoto K, Sato N, Shibuya A, Saito H, Sata M, Suzuki K, Kaneko S, Moriyama M, Omata M. A randomized trial of 24 versus 48 weeks of peginterferon alpha-2a in patients infected with chronic hepatitis C virus genotype 2 or low viral load genotype 1: a multicenter national study in Japan. Hepatol Int. 2009 3: 468-79. |
| 93. |
Mitsuyama K, Yamasaki H, Kuwaki K, Takedatsu H, Sata M．Recent understanding of leukocytapheresis (LCAP) for the treatment of inflammatory bowel disease. Curr Pharm Des. 2009 15: 2110-19. |
| 94. |
Okabe Y, Kaji Y, Ishida Y, Sakamoto T, Maeda A, Kikuta K, Tsuruta O, Sata M．Trans-gastric endoscopic drainage using a large balloon for pancreatic necrosis and abscess- Two case reports. Dig Endosc. 2009 21: S71-S74. |
| 95. |
Nakayama H, Otabe S, Yuan X, Ueno T, Hirota N, Fukutani T, Wada N, Hashinaga T, Yamada K．Effects of adiponectin transgenic expression in liver of nonalcoholic steatohepatitis model mice. Metabolism. 2009 58: 901-08. |
| 96. |
Ueno T, Torimura T, Nakamura T, Sivakumar R, Nakayama H, Otabe S, Yuan X, Yamada K, Hashimoto O, Inoue K, Koga H, Sata M．Epigallocatechin-3-gallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1c in adipose tissue. Int J Mol Med. 2009 24: 17-22. |
| 97. |
Matsuura K, Tanaka Y, Hige S, Yamada G, Murawaki Y, Komatsu M, Kuramitsu T, Kawata S, Tanaka E, Izumi N, Okuse C, Kakumu S, Okanoue T, Hino K, Hiasa Y, Sata M, Maeshiro T, Sugauchi F, Nojiri S, Joh T, Miyakawa Y, Mizokami M．Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A. J Clin Microbiol. 2009 47: 1476-83. |
| 98. |
Kobashi H, Fujioka S, Kawaguchi M, Kumada H, Yokosuka O, Hayashi N, Suzuki K, Okanoue T, Sata M, Tsubouchi H, Sato C, Kiyosawa K, Tanikawa K, Seriu T, Ishikawa H, Takaki A, Iwasaki Y, Osawa T, Takaki T, Sakaguchi K, Shiratori Y, Yamamoto K, Tenney DJ, Omata M．Two cases of development of entecavir resistance during entecavir treatment for nucleoside-naive chronic hepatitis B. Hepatol Int. 2009 3: 403-10. |
| 99. |
Naito Y, Okabe Y, Kawahara A, Taira T, Isida Y, Kaji R, Sata M, Ureshino H, Mikagi K, Kinoshita H, Yasumoto M, Kusano H, Kage M, Yano H．Usefulness of lavage cytology during endoscopic transpapillary catheterization into the gallbladder in the cytological diagnosis of gallbladder disease． Diagn Cytopathol. 2009 37: 402-06. |
| 100. |
Yasutake K, Nakamuta M, Shima Y, Ohyama A, Masuda K, Haruta N, Fujino T, Aoyagi Y, Fukuizumi K, Yoshimoto T, Takemoto R, Miyahara T, Harada N, Hayata F, Nakashima M, Enjoji M．Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: The significance of dietary cholesterol. Scand J Gastroenterol. 2009 44: 471-77. |
| 101. |
Andoh A, Tsujikawa T, Sasaki M, Mitsuyama K, Suzuki Y, Matsui T, Matsumoto T, Benno Y, Fujiyama Y．Fecal microbiota profile of crohn's disease determined by terminal restriction fragment length polymorphism (t-rflp) analysis. Aliment Pharmacol Ther. 2009 29: 424-30. |
| 102. |
Takedatsu H, Taylor KD, Mei L, McGovern DP, Landers CJ, Gonsky R, Cong Y, Vasiliauskas EA, Ippoliti A, Elson CO, Rotter JI, Targan SR．Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-κB activation. Gut. 2009 58: 60-7. |
| 103. |
Yamasaki H, Mitsuyama K, Masuda J, Kuwaki K, Takedatsu H, Sugiyama G, Yamada S, Sata M．Roles of high-mobility group box 1 in murine experimental colitis. Mol Med Report. 2009 2: 23-7. |
| 104. |
Mitsuyama K, Sata M. Therapeutic leukocytapheresis in inflammatory bowel disease: clinical efficacy and mechanisms of action. Cytotherapy. 2009 11(2):229-37. |
| 105. |
Ohtsubo K, Sata M, Kawaguchi T, Morishige S, Takata Y, Oku E, Imamura R, Seki R, Hashiguchi M, Osaki K, Yakushiji K, Kanaji T, Yoshimoto K, Ueno T, Okamura T. Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients. Int J Hematol. 2009 89(4):452-9. |
| 106. |
Naito Y, Eriguchi N, Kume T, Naito M, Nishimura M, Ohdo M, Itai N, Hayashida S, Naito H, Arikawa S, Ureshino H, Yasumoto M, Kusano H, Yano H. Multi-centric pancreatic cancer without PanIN lesion. J Hepatobiliary Pancreat Surg. 2009 16(5):699-703. |
| 107. |
Yamaguchi R, Tanaka M, Otsuka H, Yamaguchi M, Kaneko Y, Fukushima T, Terasaki H, Isobe S, Nakashima O, Yano H. Neuroendocrine small cell carcinoma of the breast: report of a case. Med Mol Morphol. 2009 42(1):58-61. |
| 108. |
Kawaguchi T, Sumie S, Itou M, Taniguchi E, Matoba T, Sata M. Clinical benefits and cost-effectiveness of 17-year treatment with low-dose interferon-alpha 2b in a patient with chronic hepatitis C: a case report. Dig Dis Sci. 2009 54(3):690-4. |
| 109. |
Sivakumar R, Koga H, Selvendiran K, Maeyama M, Ueno T, Sata M. Autocrine loop for IGF-I receptor signaling in SLUG-mediated epithelial-mesenchymal transition. Int J Oncol. 2009 34(2):329-38. |
| 110. |
Kitazaki S, Mitsuyama K, Masuda J, Harada K, Yamasaki H, Kuwaki K, Takedatsu H, Sugiyama G, Tsuruta O, Sata M. Clinical trial: comparison of alendronate and alfacalcidol in glucocorticoid-associated osteoporosis in patients with ulcerative colitis. Aliment Pharmacol Ther. 2009 29(4):424-30. |
| 111. |
Yanagimoto C, Harada M, Kumemura H, Koga H, Kawaguchi T, Terada K, Hanada S, Taniguchi E, Koizumi Y, Koyota S, Ninomiya H, Ueno T, Sugiyama T, Sata M. Niemann-Pick C1 protein transports copper to the secretory compartment from late endosomes where ATP7B resides. Exp Cell Res. 2009 315(2):119-26. |
| 112. |
Ide T, Hino T, Ogata K, Miyajima I, Kuwahara R, Kuhara K, Sata M. A randomized study of extended treatment with peginterferon alpha-2b plus ribavirin based on time to HCV RNA negative-status in patients with genotype 1b chronic hepatitis C. Am J Gastroenterol. 2009 104(1):70-5. |
| 113. |
Akiba J, Ogasawara S, Kawahara A, Nishida N, Sanada S, Moriya F, Kuwano M, Nakashima O, Yano H. N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma. Oncol Rep. 2008 Dec; 20(6):1329-35. |
| 114. |
Yano H. Inhibitory function of interferon on hepatocarcinogenesis. Oncology. 2008 75 Suppl 1:22-9. |
| 115. |
Ishida Y, Nagamatsu H, Koga H, Yoshida H, Kojiro M, Sata M. Hepatocellular carcinoma with a “nodule-in-nodule” appearance reflecting an unusual dilated pseudoglandular structure. Intern Med. 2008 47(13):1215-8. |
| 116. |
Ogata K, Kashiwagi T, Iwahashi J, Hara K, Honda H, Ide T, Kumashiro R, Kohara M, Sata M, Watanabe H, Hamada N. A mutational shift from domain III to II in the internal ribosome entry site of hepatitis C virus after interferon-ribavirin therapy. Arch Virol. 2008 153(8):1575-9. |
| 117. |
Kawaguchi T, Taniguchi E, Itou M, Mutou M, Ibi R, Shiraishi S, Okada T, Uchida Y, Otsuka M, Tonan T, Fujimoto K, Oriishi T, Tanaka S, Takakura M, Sata M. Supplement improves nutrition and stresses caused by examination-associated fasting in patients with liver cirrhosis. Hepatol Res. 2008 Dec; 38(12):1178-85. |
| 118. |
Maeyama M, Koga H, Selvendiran K, Yanagimoto C, Hanada S, Taniguchi E, Kawaguchi T, Harada M, Ueno T, Sata M. Switching in discoid domain receptor expressions in SLUG-induced epithelial-mesenchymal transition. Cancer. 2008 Nov 15; 113(10):2823-31. |
| 119. |
Kawaguchi T, Taniguchi E, Itou M, Ibi R, Okada T, Mutou M, Shiraishi S, Uchida Y, Otsuka M, Umeki Y, Oriishi T, Hayabuchi H, Tanaka S, Takakura M, Sata M. Body cell mass is a useful parameter for assessing malnutrition and severity of disease in non-ascitic cirrhotic patients with hepatocellular carcinoma or esophageal varices. Int J Mol Med. 2008 Nov; 22(5):589-94. |
| 120. |
Kuwahara R, Kumashiro R, Ide T, Koga Y, Hino T, Hisamochi A, Tanaka K, Ogata K, Koga H, Takao Y, Sata M. Predictive factors associated with the progression to hepatic failure caused by lamivudine-resistant HBV. Dig Dis Sci. 2008 Nov; 53(11):2999-3006. |
| 121. |
Moriya F, Ogasawara S, Basaki Y, Akiba J, Kojiro S, Fukahori S, Ishizaki H, Nishida N, Matsuoka K, Kojiro M, Kuwano M, Yano H. Growth inhibitory effects of pegylated IFN-alpha2b and 5-fluorouracil in combination on renal cell carcinoma cell lines in vitro and in vivo. Int J Oncol. 2008 Oct; 33(4):647-55. |
| 122. |
Yoshida T, Yamagishi S, Nakamura K, Matsui T, Imaizumi T, Takeuchi M, Koga H, Ueno T, Sata M. Pigment epithelium-derived factor (PEDF) ameliorates advanced glycation end product (AGE)-induced hepatic insulin resistance in vitro by suppressing Rac-1 activation. Horm Metab Res. 2008 Sep; 40(9):620-5. |
| 123. |
Tobaru T, Mitsuyama K, Tsuruta O, Kawano H, Sata M. Sub-classification of type VI pit patterns in colorectal tumors: relation to the depth of tumor invasion. Int J Oncol. 2008 Sep; 33(3):503-8. |
| 124. |
Mitsuyama K, Andoh A, Masuda J, Yamasaki H, Kuwaki K, Takedatsu H, Seki R, Nishida H, Tsuruta O, Sata M. Mobilization of bone marrow cells by leukocytapheresis in patients with ulcerative colitis. Ther Apher Dial. 2008 Aug; 12(4):271-7. |
| 125. |
Oku E, Kanaji T, Takata Y, Oshima K, Seki R, Morishige S, Imamura R, Ohtsubo K, Hashiguchi M, Osaki K, Yakushiji K, Yoshimoto K, Ogata H, Hamada H, Izuhara K, Sata M, Okamura T. Periostin and bone marrow fibrosis. Int J Hematol. 2008 Jul; 88(1):57-63. |
| 126. |
Kawaguchi T, Nagao Y, Matsuoka H, Ide T, Sata M. Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease. Int J Mol Med. 2008 Jul; 22(1):105-12. |
| 127. |
Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, Watanabe Y, Kojiro M, Sata M. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol. 2008 May; 15(5):1375-82. |
| 128. |
Yoshida T, Yamagishi S, Matsui T, Nakamura K, Ueno T, Takeuchi M, Sata M. Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-elicited hepatic insulin resistance via peroxisome proliferator-activated receptor-gamma activation. J Int Med Res. 2008 Mar-Apr; 36(2):237-43. |
| 129. |
Kumemura H, Harada M, Yanagimoto C, Koga H, Kawaguchi T, Hanada S, Taniguchi E, Ueno T, Sata M. Mutation in keratin 18 induces mitochondrial fragmentation in liver-derived epithelial cells. Biochem Biophys Res Commun. 2008 Feb 29; 367(1):33-40. |
| 130. |
Araki Y, Mitsuyama K, Nagae T, Tou Y, Nakagawa M, Iwatani Y, Harada M, Ozasa H, Sata M, Noake T. Leukocytapheresis for the treatment of active pouchitis: a pilot study. J Gastroenterol. 2008 43(7):571-5. |
| 131. |
Yamaguchi R, Furusawa H, Nakahara H, Inomata M, Namba K, Tanaka M, Ohkuma K, Tayama K, Fujii T, Yano H, Kage M, Kojiro M: Clinicopathological study of invasive ductal carcinoma with large central acellular zone: special reference to magnetic resonance imaging findings. Pathol Int. 2008 58: 26-30. |
| 132. |
Takahata T, Ookawa K, Suto K, Tanaka M, Yano H, Nakashima O, Kojiro M, Tamura Y, Tateishi T, Sakata Y, Fukuda S: Chemosensitivity determinants of irinotecan hydrochloride in hepatocellular carcinoma cell lines. Basic Clin Pharmacol Toxicol. 2008 102: 399-407. |
| 133. |
Komuta M, Spee B, Vander Borght S, De Vos R, Verslype C, Aerts R, Yano H, Suzuki T, Matsuda M, Fujii H, Desmet VJ, Kojiro M, Roskams T: Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology. 2008 47: 1544-56. |
| 134. |
Kawaguchi T, Nagao Y, Matsuoka H, Ide T, Sata M. Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease. Int J Mol Med. 2008 22: 105-12. |
| 135. |
Harada M, Hanada S, Toivola DM, Ghori N, Omary MB. Autophagy activation by rapamycin eliminates mouse Mallory-Denk bodies and blocks their proteasome inhibitor-mediated formation. Hepatology. 2008 47: 2026-35. |
| 136. |
Kuwahara R, Kofman AV, Landis CS, Swenson ES, Barendswaard E, Theise ND. The hepatic stem cell niche: identification by label-retaining cell assay. Hepatology. 2008 47: 1994-2002. |
| 137. |
Oku E, Kanaji T, Takata Y, Oshima K, Seki R, Morishige S, Imamura R, Ohtsubo K, Hashiguchi M, Osaki K, Yakushiji K, Yoshimoto K, Ogata H, Hamada H, Izuhara K, Sata M, Okamura T. Periostin and bone marrow fibrosis. Int J Hematol. 2008 88: 57-63. |
| 138. |
Toivola DM, Nakamichi I, Strnad P, Michie SA, Ghori N, Harada M, Zeh K, Oshima RG, Baribault H, Omary MB. Keratin overexpression levels correlate with the extent of spontaneous pancreatic injury. Am J Pathol. 2008 172: 882-92. |
| 139. |
Harada M, Strnad P, Toivola DM, Omary MB. Autophagy modulates keratin-containing inclusion formation and apoptosis in cell culture in a context-dependent fashion. Exp Cell Res. 2008 314: 1753-64. |
| 140. |
Strnad P, Tao GZ, Zhou Q, Harada M, Toivola DM, Brunt EM, Omary MB. Keratin mutation predisposes to mouse liver fibrosis and unmasks differential effects of the carbon tetrachloride and thioacetamide models. Gastroenterology. 2008 134: 1169-79. |
| 141. |
Swenson ES, Kuwahara R, Krause DS, Theise ND. Physiological variations of stem cell factor and stromal-derived factor-1 in murine models of liver injury and regeneration. Liver Int. 2008 28: 308-18. |
| 142. |
Itou M, Kawaguchi T, Taniguchi E, Sumie S, Oriishi T, Mitsuyama K, Tsuruta O, Ueno T, Sata M. Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance. J Gastroenterol Hepatol. 2008 23: 244-51. |
| 143. |
Mitsuyama K, Sata M. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease. Expert Opin Ther Targets. 2008 12: 301-12. |
| 144. |
Kumemura H, Harada M, Yanagimoto C, Koga H, Kawaguchi T, Hanada S, Taniguchi E, Ueno T, Sata M. Mutation in keratin 18 induces mitochondrial fragmentation in liver-derived epithelial cells. Biochem Biophys Res Commun. 2008 367: 33-40. |
| 145. |
Fukahori S, Yano H, Akiba J, Ogasawara S, Momosaki S, Sanada S, Kuratomi K, Ishizaki H, Moriya F, Yagi M, Kojiro M: Fucoidan, a major component of brown seaweed, prohibits the growth of human cancer cell lines in vitro. Molecular Medicine Reports. 2008 1: 537-42. |
| 146. |
Fukahori, S, Yano H, Tsuneoka M, Tanaka Y, Yagi M, Kuwano M. Tajiri T, Taguchi T, Tsuneyoshi M, and Kojiro M: Immunohistochemical expressions of Cap43 and Mina53 protein in neuroblastoma. J Ped Surg. 2007 42: 1831-40. |
| 147. |
Ishizaki H, Yano H, Tsuneoka M, Ogasawara S, Akiba J, Nishida N, Kojiro S, Fukahori S, Moriya F, Matsuoka K, Kojiro M. Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma. Pathol Int. 2007 57: 672-80. |
| 148. |
Oie S, Ono M, Fukushima H, Hosoi F, Yano H, Maruyama Y, Kojiro M, Terada T, Hirano K, Kuwano M, Yamada Y. Alteration of dihydropyrimidine dehydrogenase expression by IFN-α affects the antiproliferative effects of 5-fluorouracil in human hepatocellular carcinoma cells. Mol Cancer Ther. 2007 6: 2310-8. |
| 149. |
Sakemi R, Yano H, Ogasawara S, Akiba J, Nakashima O, Fukahori S, Sata M, Kojiro M. X-linked inhibitor of apoptosis (XIAP) and XIAP-associated factor-1 expressions and their relationship to apoptosis in human hepatocellular carcinoma and non-cancerous liver tissues. Oncol Rep. 2007 18: 65-70. |
| 150. |
Yano H, Basaki Y, Oie S, Ogasawara S, Momosaki S, Akiba J, Nishida N, Kojiro S, Ishizaki H, Moriya F, Kuratomi K, Fukahori S, Kuwano M, Kojiro M: Effects of IFN-αonα-fetoprotein expressions in hepatocellular carcinoma cells. J Interferon Cytokine Res. 2007 27: 231-38. |
| 151. |
Yutani S, Yamada A, Yoshida K, Takao Y, Tamura M, Komatsu N, Ide T, Tanaka M, Sata M, Itoh K. Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy. Vaccine. 2007 25: 7429-35. |
| 152. |
Nakamura K, Yamagishi S, Adachi H, Kurita-Nakamura Y, Matsui T, Yoshida T, Sato A, Imaizumi T. Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease. Diabetes Metab Res Rev. 2007 23: 358-71. |
| 153. |
Yamagishi S, Matsui T, Nakamura K, Yoshida T, Takeuchi M, Inoue H, Yoshida Y, Imaizumi T. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats. Ophthalmic Res. 2007 39: 92-7. |
| 154. |
Yamagishi SI, Nakamura K, Matsui T, Yoshida T, Takeuchi M, Imaizumi T. Pigment epithelium-derived factor (PEDF) blocks advanced glycation end product (AGE)-induced angiogenesis in vitro. Horm Metab Res. 2007 39: 233-5. |
| 155. |
Nakamura K, Yamagishi S, Matsui T, Yoshida T, Takenaka K, Jinnouchi Y, Yoshida Y, Ueda S, Adachi H, Imaizumi T. Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation. Am J Pathol. 2007 170: 2159-70. |
| 156. |
Nakamura K, Yamagishi S, Adachi H, Kurita-Nakamura Y, Matsui T, Yoshida T, Imaizumi T. Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes. Mol Med. 2007 13: 185-9. |
| 157. |
Nakamura K, Yamagishi S, Yoshida T, Matsui T, Imaizumi T, Inoue H, Sata M. Hydrogen peroxide stimulates pigment epithelium-derived factor gene and protein expression in the human hepatocyte cell line OUMS-29. J Int Med Res. 2007 35: 427-32. |
| 158. |
Yoshino M, Watanabe Y, Tokunaga Y, Harada E, Fujii C, Numata S, Harada M, Tajima A, Ida H. Roles of specific cytokines in bone remodeling and hematopoiesis in Gaucher disease. Pediatr Int. 2007 49: 959-65. |
| 159. |
Kawaguchi T, Taniguchi E, Itou M, Sumie S, Oriishi T, Matsuoka H, Nagao Y, Sata M. Branched-chain amino acids improve insulin resistance in patients with hepatitis C virus-related liver disease: report of two cases. Liver Int. 2007 27: 1287-92. |
| 160. |
Hanada S, Harada M, Kawaguchi T, Kumemura H, Taniguchi E, Koga H, Yanagimoto C, Maeyama M, Ueno T, Sata M. Keratin inclusions alter cytosolic protein localization in hepatocytes. Hepatol Res. 2007 37: 828-35. |
| 161. |
Sumie S, Kawaguchi T, Komuta M, Kuromatsu R, Itano S, Okuda K, Taniguchi E, Ando E, Takata A, Fukushima N, Koga H, Torimura T, Kojiro M, Sata M. Significance of glucose intolerance and SHIP2 expression in hepatocellular carcinoma patients with HCV infection. Oncol Rep. 2007 18: 545-52. |
| 162. |
Nagao Y, Myoken Y, Katayama K, Tanaka J, Yoshizawa H, Sata M. Epidemiological survey of oral lichen planus among HCV-infected inhabitants in a town in Hiroshima Prefecture in Japan from 2000 to 2003. Oncol Rep. 2007 18: 1177-81. |
| 163. |
Mitsuyama K, Matsumoto S, Masuda J, Yamasaki H, Kuwaki K, Takedatsu H, Sata M. Therapeutic strategies for the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease. Anticancer Research. 2007 27: 3749-56. |
| 164. |
Mitsuyama K, Sata M. Potential therapeutic implication of soluble gp130 in inflammatory bowel disease. Recent Advances in Inflammatory Bowel Disease. 2007 48-56. |
| 165. |
Nagaoka S, Yoshida T, Akiyoshi J, Akiba J, Torimura T, Adachi H, Kurogi J, Tajiri N, Inoue K, Niizeki T, Koga H, Imaizumi T, Kojiro M, Sata M. Serum C-reactive protein levels predict survival in hepatocellular carcinoma. Liver International. 2007 27: 1019-97. |
| 166. |
Fujiwara K, Kaneko S, Kakumu S, Sata M, Hige S, Tomita E, Mochida S; The Virus Reduction Therapy Study Group. Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load. Hepatol Res. 2007 37: 701-10. |
| 167. |
Okabe Y, Tsuruta O, Naito Y, Suga H, Sata M. Clinical evaluation of peroral cholangioscopy for biliary disease using narrow band imaging. Digestive Endoscopy. 2007 19: S121-S125. |
| 168. |
Fukushima N, Kuromatsu R, Uchiyama D, Itano S, Takata A, Ando E, Sumie S, Torimura T, Uchida M, Nakashima O, Kojiro M, Sata M. Hyperplastic nodular hepatic lesions following end-to-side portacaval shunting in childhood. Intern Med. 2007 46: 1203-8 |
| 169. |
Koga H, Ide T, Oho K, Kuwahara R, Hino T, Ogata K, Hisamochi A, Tanaka K, Kumashiro R, Toyonaga A, Sata M. Lamivudine treatment-related morphological changes of esophageal varices in patients with liver cirrhosis. Hepatol Res. 2007 37: 503-9. |
| 170. |
Nakamura T, Torimura T, Sakamoto M, Hashimoto O, Taniguchi E, Inoue K, Sakata R, Kumashiro R, Murohara T, Ueno T, Sata M. Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model. Gastroenterology. 2007 133: 91-107. |
| 171. |
Tomiyasu N, Mitsuyama K, Suzuki A, Masuda J, Yamasaki H, Kuwaki K, Takaki K, Kitazaki S, Sata M. Development of granulocyte and monocyte adsorptive apheresis in the rat dextran sodium sulfate-induced colitis model. Methods Find Exp Clin Pharmacol. 2007 29: 265-8. |
| 172. |
Kuwahara R, Saitsu H, Abe M, Takata A, Tanaka K, Hino T, Ide T, Kuromatsu R, Tanikawa K, Kage M, Kumashiro R, Sata M. Successful treatment with corticosteroid and lamivudine for autoimmune hepatitis in a patient with asymptomatic HBV infection. Dig Dis Sci. 2007 52: 908-13. |
| 173. |
Takao Y, Yamada A, Yutani S, Ono T, Nagao Y, Ando E, Ide T, Itoh K, Sata M. Serum levels of IgG to the peptide of HCV1b core at positions 35-44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at positions 2132-2140 correlated with better prognosis in HCV-infected patients. Med Microbiol Immunol. 2007 196: 157-64. |
| 174. |
Mitsuyama K, Tomiyasu N, Masuda J, Yamasaki H, Tsuruta O, Sata M. High affinity of ecabet sodium for inflamed colonic mucosa in ulcerative colitis. Dig Dis Sci. 2007 52: 1442-3. |
| 175. |
Takedatsu H, Mitsuyama K, Yamasaki H, Itou M, Toubaru T, Tomiyasu N, Tsuruta O, Sata M. Chlamydia trachomatis proctitis. Endoscopy. 2007 39: E104. |
| 176. |
Tanikawa K, Kage M, Komuta M, Nakashima O, Yano H, Yatsuhashi H, Kojiro M. Pathological analysis of oxyphilic granular hepatocytes and hepatocellular mitochondria in chronic hepatitis C. Hepatol Res. 2007 37: 425-32. |
| 177. |
Ogasawara S, Yano H, Momosaki S, Akiba J, Nishida N, Kojiro S, Moriya F, Ishizaki H, Kuratomi K, Kojiro M. Growth Inhibitory Effects of IFN-β on Human Liver Cancer Cells In Vitro and In Vivo. J Interferon Cytokine Res. 2007 27: 507-16. |
| 178. |
Seki R, Okamura T, Ide T, Kage M, Sata M, Uyesaka N, Maruyama T. Impaired filterability of erythrocytes from patients with chronic hepatitis C and effects of eicosapentaenoic acid on the filterability. J Physiol Sci. 2007 57: 43-9. |
| 179. |
Sakemi R, Yano H, Ogasawara S, Akiba J, Nakashima O, Fukahori S, Sata M, Kojiro M. X-linked inhibitor of apoptosis (XIAP) and XIAP-associated factor-1 expressions and their rela-tion-ship to apoptosis in human hepatocellular carcinoma and non-cancerous liver tissues. Oncol Rep. 2007 18: 65-70. |
| 180. |
Hanada S, Harada M, Kumemura H, Bishr Omary M, Koga H, Kawaguchi T, Taniguchi E, Yoshida T, Hisamoto T, Yanagimoto C, Maeyama M, Ueno T, Sata. Oxidative stress induces the endoplasmic reticulum stress and facilitates inclusion formation in cultured cells. J Hepatol. 2007 47: 93-102. |
| 181. |
Masuda J, Mitsuyama K, Yamasaki H, Takedatsu H, Okamura T, Andoh A, Murohara T, Asahara T, Sata M. Depletion of endothelial progenitor cells in the peripheral blood of patients with ulcerative colitis. Int J Mol Med. 2007 19: 221-8. |
| 182. |
Harada M, Strnad P, Resurreccion EZ, Ku NO, Omary MB. Keratin 18 overexpression but not phosphorylation or filament organization blocks mouse Mallory body formation. Hepatology. 2007 45: 88-96. |
| 183. |
Strnad P, Harada M, Siegel M, Terkeltaub RA, Graham RM, Khosla C, Omary MB. Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement. Gastroenterology. 2007 132: 1515-26. |
| 184. |
Zatloukal K, French SW, Stumptner C, Strnad P, Harada M, Toivola DM, Cadrin M, Omary MB. From Mallory to Mallory-Denk bodies: What, how and why? Exp Cell Res. 2007 313: 2033-49. |
| 185. |
Nagaoka S, Itano S, Nagamatsu H, Akiyoshi J, Kurogi J, Tajiri N, Kajiwara M, Sata M. Temporary indwelling catheter system via the left brachial artery: evaluation in 83 patients with hepatic tumors. Am J Roentgenol. 2007 188: 652-8. |
| 186. |
Kawaguchi T, Ide T, Taniguchi E, Hirano E, Itou M, Sumie S, Nagao Y, Yanagimoto C, Hanada S, Koga H, Sata M. Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2. Am J Gastroenterol. 2007 102: 570-6. |
| 187. |
Oku E, Imamura R, Nagata S, Takata Y, Seki R, Otsubo K, Hashiguchi M, Osaki K, Yakushiji K, Yoshimoto K, Ogata H, Sata M, Okamura T. Promyelocytic crisis of chronic myelogenous leukaemia during imatinib mesylate treatment. Acta Haematol. 2007 117: 191-6. |
